Edwards Lifesciences (NYSE: EW) and Medtronic (NYSE: MDT) are among the medtech companies praising CMS’s decision to expand Medicare coverage for TAVR to people with asymptomatic severe aortic stenosis. The finalized national coverage decision, published yesterday evening, also removes the evidence development (CED) requirement for symptomatic … [Read more...] about Edwards Lifesciences, Medtronic score CMS win over TAVR
Centers for Medicare and Medicaid Services (CMS)
Abbott earns CMS reimbursement win for Esprit drug-eluting scaffold
An Abbott (NYSE:ABT) official has shared a significant reimbursement win for its Esprit BTK drug-eluting scaffold system. On LinkedIn, SVP and President of Abbott Vascular, Julie Tyler, posted that the Centers for Medicare & Medicaid Services (CMS) approved transitional pass-through (TPT) payment status for Esprit BTK. TPT, a three-year … [Read more...] about Abbott earns CMS reimbursement win for Esprit drug-eluting scaffold
CMS adds reimbursement for cardiac ablation in ASCs
The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation technologies. In its 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, CMS added cardiac catheter ablation procedures to its ASC-covered procedures list. This … [Read more...] about CMS adds reimbursement for cardiac ablation in ASCs
Renata Medical earns Medicare win for Minima stent system
Renata Medical announced today that CMS granted a New Technology Add-on Payment (NTAP) for its Minima stent system. NTAP provides additional reimbursement to hospitals that use designated new medical technologies in the first few years of market introduction. It goes into effect on Oct. 1, 2025. The company said the reimbursement win serves as an … [Read more...] about Renata Medical earns Medicare win for Minima stent system
Boston Scientific earns Medicare reimbursement for Agent drug-coated balloon
Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB). CMS granted a new technology add-on payment (NTAP) for eligible cases using Agent. NTAP provides additional reimbursement to hospitals that use designated new medical technologies in the first few years of market introduction. … [Read more...] about Boston Scientific earns Medicare reimbursement for Agent drug-coated balloon
CMS expands TAVR coverage
The Centers for Medicare and Medicaid Services have updated the criteria for hospitals and physicians to begin or continue providing transcatheter aortic valve replacement surgery. The decision gives hospitals and providers more flexibility to meet the CMS requirements for performing TAVR, the agency said Friday. The original National Coverage … [Read more...] about CMS expands TAVR coverage
